Off-label use of medicines: The need for good practice guidelines
International Journal of Risk & Safety in Medicine · 2017-02 · 29 (1-2) · 17-23
DOI: 10.3233/jrs-170737 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Risk & Safety in Medicine, online erschienen am 01.02.2017. Verfasst von Marc Dooms und 1 weiteren Autor:innen. Beteiligte Einrichtung: Senior Orphan Drug Pharmacist, University Hospital, Leuven, Belgium. Hauptthemen laut MEDLINE: Patient Safety, Practice Guidelines as Topic. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: ‘Off-label use’ is the term used for the prescription and dispensing of a medicinal product for any indication, patient group, route of administration, dosage or treatment regimen other than that listed in the Summary of Product Characteristics. OBJECTIVE: In this article the authors present a brief overview of current practices of off-label use in Europe and the applicable European law and jurisprudence. They then go on to present a set of guidelines for best practice in off-label use which underlines the need for guidance on prescription to be firmly rooted in the need to ensure patient safety above all other concerns. METHODS: The article was written from desk research and expert engagement, including a presentation and Q&A in the European Parliament. RESULTS: This article intends to demonstrate that off-label use entails increased risks for patients, especially when it is not underpinned by rigorous clinical studies or the reporting routes for use are not well defined. CONCLUSIONS: Europe is seeing a growing trend the promotion of off-label prescription of medicinal products for reasons other than pure medical need, including motives such as cost-containment. This poses a numer of questions for the ethical and legal framework for medicine prescription and dispensing in Europe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Senior Orphan Drug Pharmacist, University Hospital, Leuven, Belgium.
- Partner, White & Case LLP, Brussels, Belgium.
Zitieren
APA
Dooms, M., & Killick, J. (2017). Off-label use of medicines: The need for good practice guidelines. International Journal of Risk & Safety in Medicine, 29(1-2), 17-23. https://doi.org/10.3233/jrs-170737
Vancouver
Dooms M, Killick J. Off-label use of medicines: The need for good practice guidelines. International Journal of Risk & Safety in Medicine. 2017;29(1-2):17-23. doi:10.3233/jrs-170737
BibTeX
@article{Dooms2017,
author = {Dooms, Marc and Killick, James},
title = {Off-label use of medicines: The need for good practice guidelines},
journal = {International Journal of Risk & Safety in Medicine},
year = {2017},
volume = {29},
number = {1-2},
pages = {17--23},
doi = {10.3233/jrs-170737}
}
EUVIMED